Ameritas Investment Partners’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $56.3K | Hold |
|
|||||
|
2025
Q2 | $97.7K | Buy |
|
|||||
|
2025
Q1 | $60.6K | Hold |
|
|||||
|
2024
Q4 | $50.9K | Hold |
|
|||||
|
2024
Q3 | $69.9K | Hold |
|
|||||
|
2024
Q2 | $41K | Buy |
|
|||||
|
2024
Q1 | $20.5K | Hold |
|
|||||
|
2023
Q4 | $11K | Hold |
|
|||||
|
2023
Q3 | $7.57K | Hold |
|
|||||
|
2023
Q2 | $13.4K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $4K | Hold |
|
|||||
|
2021
Q4 | $7K | Hold |
|
|||||
|
2021
Q3 | $10K | Hold |
|
|||||
|
2021
Q2 | $32K | Hold |
|
|||||
|
2021
Q1 | $45K | Buy |
|